Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.

Journal of Alzheimer's disease : JAD·2025
Same author

A man with weakness and hearing loss.

Practical neurology·2025
Same author

Natural history of adult-onset metachromatic leukodystrophy.

Journal of neurology·2025
Same author

Use and misuse of domperidone in patients living with Parkinson disease in France.

Fundamental & clinical pharmacology·2025
Same author

[Memory diseases].

La Revue du praticien·2024
Same author

Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.

Genetics in medicine : official journal of the American College of Medical Genetics·2024
Same journal

[Edgar Morin and Complexity: The Inspiration Behind the Specifications Framework for the Gerontopoles of the French Union of Gerontopoles].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
Same journal

[Case report: Spontaneous periodic hypotermia in a geriatric patient].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
Same journal

[Perceptions of healthcare professionals on frailty screening in outpatient care: a qualitative study (Calvados, France)].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
Same journal

[Impact of Covid-19 pandemic lockdown on the psychobehavioral symptoms of nursing home residents with neurocognitive disorders: a multicenter retrospective study].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
Same journal

[Risk factors for mortality in geriatric hospitalized patients with respiratory syncytial virus: the FAMHous study].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
Same journal

[Preliminary validation of the Quebec French version of the Memory Binding Test: Comparison with the Rey Auditory Verbal Learning Test in adults aged 55 and older].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

["Reversible" dementia in 2011].

Jean-Marc Michel1, François Sellal

  • 1CMRR de Strasbourg-ColmarCMRR de Strasbourg-ColmarCMRR de Strasbourg-Colmar. jeanmarc.michel@ch-colmar.fr

Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement
|June 22, 2011
PubMed
Summary
This summary is machine-generated.

Reversible dementias are rare, often caused by neurosurgical issues like hydrocephalus. Early detection through investigations can identify treatable causes and improve patient outcomes.

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Experiment Videos

Last Updated: May 31, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Area of Science:

  • Neurology
  • Geriatrics

Context:

  • Reversible dementias represent a small fraction of all dementia cases.
  • Neurosurgical causes are the most common etiology for reversible dementia.

Purpose:

  • To review the etiologies and diagnostic approaches for reversible dementias.
  • To highlight the importance of ancillary investigations in identifying treatable causes.

Summary:

  • Reversible dementias account for about 1.5% of all dementias, with neurosurgical conditions like normal pressure hydrocephalus being frequent.
  • While often rare, infectious, endocrine, or vitamin deficiency causes should be investigated as they may be reversible.
  • Identifying and treating reversible factors can improve clinical conditions in a significant portion of dementia patients.

Impact:

  • Emphasizes the importance of a thorough diagnostic workup for dementia.
  • Suggests that identifying treatable conditions can mitigate dementia progression and improve patient management.